DOBRINA, ALDO
 Distribuzione geografica
Continente #
NA - Nord America 6.542
EU - Europa 2.506
AS - Asia 2.461
SA - Sud America 319
Continente sconosciuto - Info sul continente non disponibili 272
AF - Africa 101
OC - Oceania 10
Totale 12.211
Nazione #
US - Stati Uniti d'America 6.469
SG - Singapore 855
PL - Polonia 662
CN - Cina 655
UA - Ucraina 440
IT - Italia 326
SE - Svezia 299
HK - Hong Kong 275
BR - Brasile 254
VN - Vietnam 221
FI - Finlandia 151
FR - Francia 126
KR - Corea 123
GB - Regno Unito 111
BD - Bangladesh 87
DE - Germania 87
RU - Federazione Russa 87
TR - Turchia 87
MA - Marocco 74
BG - Bulgaria 68
IE - Irlanda 68
IN - India 39
CA - Canada 29
JP - Giappone 19
MX - Messico 19
AR - Argentina 18
CH - Svizzera 18
NL - Olanda 15
IQ - Iraq 14
SA - Arabia Saudita 14
BE - Belgio 13
EC - Ecuador 13
ZA - Sudafrica 11
ID - Indonesia 10
AU - Australia 9
CO - Colombia 9
AE - Emirati Arabi Uniti 8
ES - Italia 8
VE - Venezuela 8
PH - Filippine 7
PK - Pakistan 6
DZ - Algeria 5
IL - Israele 5
IR - Iran 5
KZ - Kazakistan 5
MY - Malesia 5
RO - Romania 5
CL - Cile 4
HN - Honduras 4
PA - Panama 4
AT - Austria 3
BO - Bolivia 3
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
GR - Grecia 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
MN - Mongolia 3
NI - Nicaragua 3
PE - Perù 3
PR - Porto Rico 3
PY - Paraguay 3
UY - Uruguay 3
CZ - Repubblica Ceca 2
EU - Europa 2
JO - Giordania 2
KW - Kuwait 2
MD - Moldavia 2
NP - Nepal 2
SN - Senegal 2
SV - El Salvador 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
AZ - Azerbaigian 1
BB - Barbados 1
ET - Etiopia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MG - Madagascar 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.943
Città #
Woodbridge 717
Fairfield 603
Ashburn 600
Warsaw 591
Singapore 512
Ann Arbor 485
Houston 449
Jacksonville 387
Wilmington 335
Chandler 308
San Jose 292
Hong Kong 270
Seattle 262
Cambridge 218
Hefei 156
Princeton 135
Beijing 131
Seoul 121
Boardman 108
Council Bluffs 108
Chicago 91
Columbus 90
Santa Clara 90
Izmir 82
Casablanca 69
Dublin 68
Sofia 68
Zgierz 66
Ho Chi Minh City 63
Milan 63
Trieste 60
Lauterbourg 59
Los Angeles 59
Hanoi 58
Buffalo 50
Moscow 43
Dearborn 35
Dallas 32
Frankfurt am Main 32
The Dalles 29
San Diego 28
Phoenix 26
São Paulo 24
New York 23
Falls Church 21
Munich 21
Düsseldorf 20
Jinan 18
London 17
Nanjing 17
Washington 17
Des Moines 14
Brooklyn 13
Brussels 13
Guangzhou 13
Turku 13
Verona 13
Bern 12
Tokyo 12
Shenyang 11
Tianjin 11
Helsinki 10
Miano 10
Norwalk 10
Atlanta 9
Jersey City 9
Kunming 9
Montreal 9
Orem 9
Queens 9
Da Nang 8
Denver 8
Hebei 8
Shanghai 8
Belo Horizonte 7
Nanchang 7
Quito 7
Rome 7
Shenzhen 7
Toronto 7
Auburn Hills 6
Brasília 6
Dong Ket 6
Haiphong 6
Hangzhou 6
Johannesburg 6
Long Branch 6
Paris 6
Rio de Janeiro 6
San Francisco 6
Stockholm 6
Campinas 5
Fuzhou 5
Indiana 5
Medellín 5
Melbourne 5
Naples 5
Nuremberg 5
Poplar 5
Portsmouth 5
Totale 8.621
Nome #
Hepatic PPARs: their role in liver physiology, fibrosis and treatment 441
Intracellular function of interleukin-1 receptor antagonist in ischemic cardiomyocytes. 426
Alterations in the interleukin-1/interleukin-1 receptor antagonist balance modulate cardiac remodeling following myocardial infarction in the mouse. 406
Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. 257
Sudden coronary death, fatal acute myocardial infarction and widespread coronary and myocardial inflammation. 256
Interleukin-1 receptor antagonist levels correlate with extent of myocardial loss in patients with acute myocardial infarction. 242
Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase 229
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 224
Plasma concentrations of interleukin-2 soluble receptor in mild ischaemic left ventricular dysfunction. 222
Widespread myocardial inflammation and infarct-related artery patency. 221
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction 217
Disorders of neutrophil functions 207
Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo 206
Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. 206
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 205
Early interleukin-1 receptor antagonist elevation in patients with acute myocardial infarction. 204
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs 200
Effect of acylated flavonoids on neutrophil adherence to endothelial cells. 194
Complement-endothelial cell interactions: pathophysiological implications. 194
Apoptosis and post-infarction left ventricular remodeling. 194
Right ventricular dilatation after left ventricular acute myocardial infarction is predictive of extremely high peri-infarctual apoptosis at postmortem examination in humans. 191
Soluble interleukin-2 receptor: is there a role in ischaemic cardiomyopathy? 186
High-risk clinical features predict increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery. 185
Complement-endothelial cell interactions: pathophysiological implications. 182
Inhibition of neutrophil adherence to vascular endothelial cells a new acylated flavonoid. 177
Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation. 177
Heterogeneity of macrophages as revealed by studies on their oxidative metabolism 177
Increased myocardial apoptosis in patients with unfavorable left ventricular remodeling and early symptomatic post-infarction heart failure. 175
Effects of acylated flavonoids on neutrophil adherence to endothelial cells 171
Portosystemic shunts in a large cohort of patients with liver cirrhosis: detection rate and clinical relevance 170
Cirrhotic cardiomyopathy. 168
New therapeutic approaches to liver fibrosis: a practicable route? 165
Prostacyclin in sepsis: a systematic review. 164
Multiple receptors on human monocytes are involved in adhesion to cultured human endothelial cells. 162
Hemodynamic effects of a prostacyclin analog (iloprost) on portal flow velocity and volume and visceral artery circulation in patients with lower limb arteriopathy. 160
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. 160
Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. 156
Iloprost: an adjunctive approach to chronic viral hepatitis treatment. 154
CD11/CD18-independent neutrophil adherence to inducible endothelial-leucocyte adhesion molecules (E-LAM) in vitro. 154
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention. 154
Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease. 150
Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. 144
Prostacyclin in liver disease: a potential therapeutic option. 143
Metabolic properties of freshly isolated bovine endothelial cells. 142
Enhanced portal flow velocity and volume following Iloprost treatment 141
Complement-endothelial cell interaction: pathophysiological implications. 140
Endothelial cell E- and P-selectin and vascular cell adhesion molecule-1 function as signaling receptors. 139
Identification and partial characterization of a cytolytic toxin produced by Gardnerella vaginalis. 138
Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes 138
The respiratory burst and endothelial cells 137
Improved hepatic perfusion after iloprost infusion in patients with HCV chronic infection: a pilot study with possible therapeutic implications. 136
Iloprost enhances portal flow velocity and volume in patients with systemic sclerosis. 134
Phorbol ester causes down-regulation of CD11/CD18-independent neutrophil adherence to endothelium. 131
Leptospira interrogans and Leptospira peptidoglycans induce the release of tumor necrosis factor alpha from human monocytes. 126
Inflammatory markers and coronary interventions: a potentially useful follow-up modality after stenting. 126
Biological activity of a peptidoglycan extracted from Leptospira interrogans: in vitro studies. 124
Postmeal portal flow variations in HCV-related chronic hepatitis and liver cirrhosis with and without hyperdynamic syndrome. 122
Isolation of metabolically active endothelial cells in high yield from bovine cavernous bodies. A model for functional studies on freshly isolated microvascular endothelial cells. 114
[Mediastinal lymphangioma (with a report on 3 personal cases)]. 110
null 108
The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. 102
null 101
null 101
Inhibition of netrophil adherence to vascular endothelial cells by a new acylated flavonoid. 98
null 96
Neutrophil-endothelial cell interaction:evidence for and mechanisms of bovine microvascular endothelial cells self protection from hydrogen peroxide-induced oxidative stress 92
Leptospira icterohemorrhagiae and leptospire peptidoglycans induce endothelial cell adhesiveness for polymorphonuclear leukocytes 91
TUMOR NECROSIS FACTOR-ALPHA EXHIBITS GREATER PROINFLAMMATORY ACTIVITY THAN LYMPHOTOXIN IN VITRO. 88
null 80
High-Risk clinical increased post-infarction myocardial apoptosis and the benefits as a result of an open infarct-related artery 77
null 67
null 64
Mechanisms of eosinophil adherence to cultured vascular endothelial cell. Eosinophils bind to the cytokine-induced endothelial ligand Vascular Cell Adhesion Molecule-1 via the Very Late Activation antigen-4 integrin receptor. 63
null 61
null 48
Totale 12.211
Categoria #
all - tutte 35.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022640 0 0 0 51 12 61 24 32 83 70 81 226
2022/2023916 81 85 62 138 95 171 17 55 156 2 40 14
2023/2024532 38 31 27 27 62 67 99 97 5 11 29 39
2024/20251.004 18 16 54 83 169 89 89 59 103 108 92 124
2025/20263.029 146 193 244 375 247 282 438 104 288 426 147 139
2026/2027495 88 181 226 0 0 0 0 0 0 0 0 0
Totale 12.211